Glossary Entry

Individual Case Safety Report

An Individual Case Safety Report is the core pharmacovigilance record used to capture a single suspected adverse event and support patient safety decisions, case evaluation, and regulatory reporting.

Definition

An Individual Case Safety Report, or ICSR, is a structured safety report that documents one reported adverse reaction, medication error, product quality complaint, or other suspected safety event involving a medicinal product. It is the basic unit of pharmacovigilance data and is used to capture the patient context, event details, seriousness, outcome, and relevant follow-up information.

In practice, an ICSR may originate from spontaneous reports, clinical trials, literature, or healthcare providers. Each case is reviewed for completeness and assessed for medical relevance before being entered into safety systems and evaluated for potential signal development or regulatory action.

Why It Matters

ICSRs are the foundation of post-marketing safety monitoring. They allow companies to identify emerging safety concerns early, determine whether a reported event is clinically meaningful, and ensure that reports are submitted within the required timelines to regulators and other stakeholders.

For sponsors and market authorization holders, strong ICSR handling supports both compliance and decision-making. Poor case quality can delay assessment, weaken oversight, and create avoidable risk for patients and the organization. In a fast-moving regulatory environment, reliable case intake and follow-up are essential.

How It Relates to MedNova

MedNova supports organizations with practical pharmacovigilance processes that improve the quality, consistency, and timeliness of case handling. Our work can include process design, case intake oversight, safety reporting readiness, and support for teams managing product safety across complex regional environments.

We also help organizations align their pharmacovigilance operations with the expectations of local and international stakeholders, including where cross-functional coordination is required between safety, medical, regulatory, and quality teams.

Frequently Asked Questions

What information is included in an ICSR?

Typically, an ICSR includes details of the patient, suspected product, event description, seriousness, medical history, chronology, and any relevant follow-up information. The level of detail can significantly influence case assessment and reporting decisions.

How is an ICSR different from an aggregate report?

An ICSR describes a single case, while aggregate reporting summarizes trends across multiple cases or time periods. Both are important, but they serve different purposes in safety management and regulatory reporting.

Why is case quality so important?

High-quality ICSRs improve signal detection, reduce reporting delays, and strengthen the reliability of safety evaluations. Incomplete or inconsistent case narratives can undermine both internal decisions and regulatory confidence.

Need expert support?

Whether you are strengthening case processing workflows or preparing for more complex safety oversight, MedNova can help you build robust processes that support compliance and operational clarity.

Book a Consultation
Practical next step: For teams that want to turn this guidance into action, MedNova offers training and consulting and a downloadable checklist PDF that help connect regulatory readiness, safety, and documentation practices.